FOR IMMEDIATE RELEASE 
-------------------------- 
Of interest to editors and journalists covering: 
Medical Technology, Biotech, Pharmaceutical, Software/Bioinformatics


Direct Wireless Enters into a Letter of Agreement 
to Acquire Fractal Genomics

SAN FRANCISCO, CALIF. - September 2, 2003 (Send2Press Newswire) -- Direct
Wireless Communications, Inc. (OTCBB: DWCM) today announced the signing of
a binding Letter of Agreement to acquire Fractal Genomics in San
Francisco, California.  Fractal Genomics was founded by Sandy Shaw, a
former bioinformatics specialist at the University of California, San
Francisco and former computer scientist and software engineer with over
twenty years of experience at Bell Labs, Lockheed Electronics and the
University of Hawaii.

Fractal Genomics utilizes its patent protected technology to find, link
and model patterns of similarity hidden in large amounts of information,
such as the clinical databases used for diagnostic and drug discovery and
has patent protected protein and pathway discovery in leukemia and lung
development, which could lead to the identification of novel proteins that
could be used to develop diagnostic markers and drug targets.

"We are extremely pleased to have signed a binding Letter of Agreement to
acquire the patent protected computational software used in diagnosis and
drug discovery developed by Fractal Genomics," stated Bill G. Williams,
Chief Executive Officer of Direct Wireless.  "Fractal Genomics has
successfully used its Fractal Genomics Modeling (FGM) software to analyze
databases from MD Anderson Cancer Center, St. Jude Children's Hospital and
the Alvin J. Siteman Cancer Center at Washington University. We are also
pleased to have Mr. Shaw serve as the Vice-President and Director of
Fractal Based Information Technology."

"I am looking forward to joining the impressive and accomplished
scientific staff at Direct Wireless," remarked Sandy Shaw, founder of
Fractal Genomics. "I welcome the opportunity to work closely with
pharmaceutical and diagnostic companies worldwide to assist them in
identifying novel proteins and pathways critical to diagnosing and
treating patients with devastating diseases like cancer, heart disease,
obesity and AIDS."

For more information, visit http://www.FractalGenomics.com


MEDIA CONTACT:
Robert S. Braswell IV
of Direct Wireless Communications, Inc. 
Info@dwcell.com
+1-512-583-4500




# # #



--------------------------------------------------------------------------- 
*Important Note: to reach the person sending the news release contact:
Info@dwcell.com

If used for publication, please send specimen copy.
[source of news = Direct Wireless Communications, Inc. (OTCBB: DWCM)]
ref: http://www.send2press.com/2archive/2003/pr_03_0902-dwcm.txt 
---------------------------------------------------------------------------
prn/R/4c/ CA / SAN FRANCISCO, CALIFORNIA